Logo

Sigma-Aldrich Signs on New Batch of Academics for RNAi Partnership Program

Sep 15, 2006
NEW YORK (GenomeWeb News) – Sigma-Aldrich said today that researchers from six academic institutions have joined its RNAi Partnership Program.
 
The researchers are from The Wistar Institute, Mayo Clinic, Tufts University, Princeton University, the Moores Cancer Center at the University of California, San Diego, and Washington University in St. Louis.
 
Sigma formed its RNAi Partnership Program in April to provide researchers with RNAi tools, including products, new technologies, and reagents, as well as access to Sigma-Aldrich’s functional genomic portfolio.
 
The portfolio includes access to the lentivirus-based MISSION TRC shRNA libraries that target more than 15,000 human and mouse genes.

Filed under

Gene Silencing/Gene Editing
RNAi
Breaking News
The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.